US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 2.360
  • -0.230-8.88%
Close May 17 16:00 ET
  • 2.370
  • +0.010+0.42%
Post 19:42 ET
447.13MMarket Cap-2622P/E (TTM)

Esperion Therapeutics Key Stats

Esperion Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

137.74M

+466.14%
EPS(YoY)

0.34

+143.04%

Buy

Apr 30, 2024

Esperion Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 67.530M--
--2024/Q2-- / 46.249M--
May 7, 20242024/Q1137.735M / 83.888M--
Feb 27, 20242023/Q432.250M / 28.701M--
Nov 7, 20232023/Q333.969M / 30.147M--
Aug 1, 20232023/Q225.786M / 24.639M--
May 9, 20232023/Q124.329M / 21.967M--
Feb 21, 20232022/Q418.818M / 20.604M--
Nov 1, 20222022/Q318.980M / 19.683M--
Aug 2, 20222022/Q218.841M / 18.617M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 67.530M--
--2024/Q2-- / 46.249M--
May 7, 20242024/Q1137.735M / 83.888M--
Feb 27, 20242023/Q432.250M / 28.701M--
Nov 7, 20232023/Q333.969M / 30.147M--
Aug 1, 20232023/Q225.786M / 24.639M--
May 9, 20232023/Q124.329M / 21.967M--
Feb 21, 20232022/Q418.818M / 20.604M--
Nov 1, 20222022/Q318.980M / 19.683M--
Aug 2, 20222022/Q218.841M / 18.617M--

Unlock Free Earnings Estimates

Esperion Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Buy

  • Buy

    71.43%
  • Hold

    28.57%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg